IMMU-09. Interim analysis from BrainChild-03: Seattle Children’s Locoregional B7-H3 CAR T Cell Trial for Children with Recurrent Central Nervous System Tumors and DIPG
Nicholas A. Vitanza(Seattle Children's Hospital), Julie Park(University of California, Los Angeles), Jason S. Hauptman(Seattle Children's Hospital), Rimas J. Orentas(Capital Caring), Ashley Wilson(Center for Infectious Disease Research), Dickson T. Chen(Seattle Children's Hospital), Erin Crotty(Seattle Children's Hospital), Catherine M. Albert(Seattle Children's Hospital), Sarah Leary(Seattle Children's Hospital), Sophie Tahiri(Seattle Children's Hospital), Wenjun Huang(Chengdu Research Base of Giant Panda Breeding), Bonnie Cole(Howard Hughes Medical Institute), Rebecca Gardner(Seattle Children's Hospital), Carrie Myers(Seattle Children's Hospital), Navin Pinto(Seattle Children's Hospital), Michael Meechan(Seattle Children's Hospital), Samuel R. Browd(Seattle Children's Hospital), Matthew C. Biery(Seattle Children's Hospital), Juliane Gust(University of Washington), Amy S. Lee(University of Southern California), Michael C. Jensen(Seattle Children's Hospital)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k